Readability & Display

Unofficial consolidated textConsolidated 2026-01-01English

Annex XVI

Reproduced from official EUR-Lex 1/1/2026.

Official catalogue · non-binding

Related guidance (30)

Current English catalogue entries that refer to Annex XVI. Guidance is non-binding and kept separate from the regulation text.

Browse topics
MDCG 2023-6Guidance on demonstration of equivalence for Annex XVI products - A guide for manufacturers and notified bodiesDecember 2023
MDCG 2023-5Guidance on qualification and classification of Annex XVI products - A guide for manufacturers and notified bodiesDecember 2023
Q&AQ&A on transitional provisions for products without an intended medical purpose covered by annex XVI of the MDRSeptember 2023
Manual on BorderlineManual on borderline and classification under Regulations (EU) 2017/745 and 2017/746 v5 Background note on the use of the Manual on borderline and classification for medical devices under the Directives.April 2026
MDCG 2021-24 rev.1Guidance on classification of medical devicesApril 2026
MDCG 2019-15 rev.1Guidance notes for manufacturers of class I medical devicesDecember 2019
MDCG 2024-10Clinical evaluation of orphan medical devicesJune 2024
MDCG 2024-5 MDCG 2024-5 Appendix AGuidance on the Investigator’s Brochure contentAppendix A of the MDCG 2024-5April2024April2024
Show all 30 guidance documentsShow only the first 8
MDCG 2021-6 - rev.1Regulation (EU) 2017/745 – Questions & Answers regarding clinical investigationDecember 2023
MDCG 2020-13 - Word versionClinical evaluation assessment report templateJuly 2020
MDCG 2020-5Guidance on clinical evaluation – EquivalenceApril 2020
MDCG 2019-9 - rev.1Summary of safety and clinical performanceMarch 2022
MDCG 2026-32026 EMDN Version HistoryApril 2026
MDCG 2026-1Summary of EMDN 2025 Submissions and outcome of annual revisionApril 2026
MDCG 2025-32024-2025 Annual Revision Change LogJanuary 2025
MDCG 2021-12 rev.2FAQ on the European Medical Device Nomenclature (EMDN)April 2026
MDCG 2023-1Guidance on the health institution exemption under Article 5(5) of Regulation (EU) 2017/745 and Regulation (EU) 2017/746January 2023
MDCG 2021-27 - rev.1Questions and Answers on Articles 13 & 14 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746December 2023
MDCG 2022-16Guidance on Authorised Representatives Regulation (EU) 2017/745 and Regulation (EU) 2017/746October 2022
MDCG 2025-9Guidance on Breakthrough Devices (BtX) under Regulations 2017/745 & 2017/746Note: Pilot to roll-out the guidance is expected to be launched in Q2 2026December 2025
MDCG 2025-6FAQ on Interplay between the Medical Devices Regulation (MDR) & In vitro Diagnostic Medical Devices Regulation (IVDR) and the Artificial Intelligence Act (AIA)June 2025
InfographicIs your software a Medical Device?March 2021
MDCG 2019-11 rev.1Qualification and classification of software - Regulation (EU) 2017/745 and Regulation (EU) 2017/746June 2025
MDCG 2021-17Applied-for scope of designation and notification of a conformity assessment body – Regulation (EU) 2017/745 (MDR)July 2021
MDCG 2019-14Explanatory note on MDR codesDecember 2019
MDCG 2019-7 - rev.1Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘person responsible for regulatory compliance’ (PRRC)December 2023
MDCG 2023-3 rev.2Questions and Answers on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746January 2025
MDCG 2022-21Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745December 2022
MDCG 2021-5 rev.1Guidance on standardisation for medical devicesJuly 2024
MDCG 2018-1 rev.4Guidance on basic UDI-DI and changes to UDI-DIApril 2021

Reader references